EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+15.67%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$2B
AUM Growth
+$2B
(+16%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
6.62%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
148
New
13
Increased
88
Reduced
14
Closed
14
Top Buys
| 1 |
Canadian Solar
CSIQ
|
$17.4M |
| 2 |
ATHN
Athenahealth, Inc.
ATHN
|
$17.1M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$16.6M |
| 4 |
Cirrus Logic
CRUS
|
$14.8M |
| 5 |
CAFD
8point3 Energy Partners LP Class A shares
CAFD
|
$12.7M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$27.7M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$20.4M |
| 3 |
SUNE
SUNEDISON, INC COM
SUNE
|
$20.3M |
| 4 |
TERP
TerraForm Power, Inc
TERP
|
$15.5M |
| 5 |
Cognex
CGNX
|
$7.05M |
Sector Composition
| 1 | Healthcare | 30.11% |
| 2 | Technology | 22.93% |
| 3 | Consumer Discretionary | 12.85% |
| 4 | Industrials | 7.77% |
| 5 | Real Estate | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
TG Therapeutics
TGTX
$5.03B
| $6.41M | 0.32% |
537,600
+161,800
| +43% | +$1.93M |
|
77
Seres Therapeutics
MCRB
$162M
| $6.25M | 0.31% |
178,200
+70,670
| +66% | +$2.48M |
|
78
Dynavax Technologies
DVAX
$1.19B
| $6.04M | 0.3% |
250,000
-30,700
| -11% | -$742K |
|
|
XLRN
79
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.02M | 0.3% |
123,500
+36,400
| +42% | +$1.77M |
|
|
CEMP
80
DELISTED
Cempra, Inc.
CEMP
| $5.76M | 0.29% |
184,900
+28,100
| +18% | +$875K |
|
81
Repligen
RGEN
$6.54B
| $5.72M | 0.29% |
202,000
+23,600
| +13% | +$668K |
|
|
AGTC
82
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $5.69M | 0.28% |
279,100
+28,600
| +11% | +$583K |
|
83
Voyager Therapeutics
VYGR
$204M
| $5.48M | 0.27% |
+250,000
| New | +$5.48M |
|
84
Ormat Technologies
ORA
$5.51B
| $5.47M | 0.27% |
+150,000
| New | +$5.47M |
|
|
STML
85
DELISTED
Stemline Therapeutics, Inc.
STML
| $5.37M | 0.27% |
851,400
+116,400
| +16% | +$734K |
|
|
GBT
86
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.33M | 0.27% |
165,000
+149,521
| +966% | +$4.83M |
|
|
GWPH
87
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.1M | 0.26% |
73,500
+4,800
| +7% | +$333K |
|
88
Xencor
XNCR
$594M
| $5.03M | 0.25% |
344,000
-22,600
| -6% | -$330K |
|
|
TCON
89
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $4.78M | 0.24% |
517,700
+113,788
| +28% | +$1.05M |
|
90
Cidara Therapeutics
CDTX
$1.61B
| $4.53M | 0.23% |
264,000
+88,600
| +51% | +$1.52M |
|
|
DRNA
91
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.48M | 0.22% |
377,000
+61,700
| +20% | +$732K |
|
92
Vertex Pharmaceuticals
VRTX
$102B
| $4.35M | 0.22% |
+34,600
| New | +$4.35M |
|
|
OMED
93
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $4.28M | 0.21% |
190,000
+43,100
| +29% | +$972K |
|
94
AtriCure
ATRC
$1.73B
| $4.04M | 0.2% |
180,000
-4,100
| -2% | -$92K |
|
|
JUNO
95
DELISTED
Juno Therapeutics, Inc.
JUNO
| $3.96M | 0.2% |
+90,000
| New | +$3.96M |
|
96
Insmed
INSM
$30.3B
| $3.81M | 0.19% |
210,000
+65,400
| +45% | +$1.19M |
|
|
IMDZ
97
DELISTED
Immune Design Corp.
IMDZ
| $3.61M | 0.18% |
180,000
+25,499
| +17% | +$512K |
|
98
uniQure
QURE
$954M
| $2.89M | 0.14% |
174,900
+20,000
| +13% | +$331K |
|
99
CytomX Therapeutics
CTMX
$350M
| $2.09M | 0.1% |
+100,000
| New | +$2.09M |
|
100
Accuray
ARAY
$165M
| $2.07M | 0.1% |
306,200
-58,400
| -16% | -$394K |
|